IGC Pharma (IGC) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

IGC Pharma Reports Q2 EPS (2c) Vs. (5c) Last Year
TipRanksNov 14 09:35 ET
India Globalization Capital GAAP EPS of -$0.02 Beats by $0.01, Revenue of $0.41M Beats by $0.21M
Seeking AlphaNov 14 08:43 ET
Express News | IGC Pharma Inc: Qtrly Loss per Share $0.02
ReutersNov 14 08:42 ET
Express News | IGC Pharma Q2 Revenue USD 412 Thousand
ReutersNov 14 08:31 ET
Express News | IGC Pharma Q2 Pretax Profit USD -1.717 Million
ReutersNov 14 08:31 ET
Express News | IGC Pharma Q2 Operating Income USD -1.76 Million
ReutersNov 14 08:31 ET

Comments

Trytosaveabit

Oct 22 14:34

Hmm! News

$IGC Pharma (IGC.US)$ $Canopy Growth (CGC.US)$ $Aurora Cannabis (ACB.US)$ $Cronos Group (CRON.US)$ $GrowGeneration (GRWG.US)$
Legislative Committee In Ireland Calls For Marijuana Legalization And Decriminalization Of 'All Illicit Drugs'" - Marijuana Moment
Benzinga· 2 mins ago
After lawmakers in Ireland delayed a vote on marijuana legalization earlier this year in favor of further studying the issue, a special legislative committee on drug policy has published an interim report with nearly 60 re...

2

Jaguar8

Oct 17 07:33

NEWS

$IGC Pharma (IGC.US)$
IGC Pharma Announces Patient Enrollment at Toronto's Baycrest in Phase 2 Trial Investigating IGC-AD1
IGC Pharma (NYSE American:IGC) has announced the enrollment of patients at Baycrest Academy for Research and Education in Toronto, Canada, for its ongoing Phase 2 trial of IGC-AD1, a treatment for agitation in Alzheimer's dementia. IGC-AD1 is a partial CB1 receptor agonist with anti-neuroinflammatory properties, targeting key pathways involved in Alzheimer's disease patho...

Abela

Sep 27 15:49

$IGC Pharma (IGC.US)$ com boy move🚀🚀🚀

FattyChick

Sep 18 07:02

$IGC Pharma (IGC.US)$ Alzheimar Pm play.

Jaguar8

Aug 22 08:02

NEWS

$IGC Pharma (IGC.US)$
IGC Pharma Announces Research Demonstrating New Molecule IGC-1C Targets Tau Protein in Alzheimer's Disease
IGC Pharma (NYSE American: IGC) has announced promising preclinical research on IGC-1C, a novel small-molecule modulator. The findings reveal that IGC-1C targets tau protein phase separation, offering new possibilities for treating neurodegenerative diseases.
Additionally, IGC-1C has been identified as a potential GLP-1 receptor agonist, showing promise for weight...

6

IGC IGC Pharma

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target